New & Projected Patent Expirations

Size: px
Start display at page:

Download "New & Projected Patent Expirations"

Transcription

1 Asacol HD (Apil) Mesalamine delayed-release tablet 800 mg Zydus Generic now available Avage (Allergan) Tazarotene 0.1% cream Taro Generic now available Axiron (Eli Lilly) Testosterone transdermal solution Perrigo, Teva Generic now available Azilect (Teva) Rasagiline mesylate tablet Alvogen (Orchid), Teva (authorized generic) Generic now available Beyaz (Bayer) Drospirenone/Ethinyl estradiol/levomefolate calcium Teva (Rajani) Generic now available Busulfex (Otsuka) Busulfan injection American Regent (Luitpold), Sagent (Pharmascience) Generic now available Clolar (Genzyme) Clofarabine Fresenius Kabi (Abon) Generic now available Cordran (Aqua) Flurandrenolide 0.05% lotion Perrigo Generic now available Effient (Eli Lilly) Prasugrel Mylan, Prasco Labs (authorized generic) Generic now available Epiduo (Galderma) Adapalene 0.1%/Benzoyl peroxide 2.5% Teva Generic now available Lialda (Shire) Mesalamine delayed-release tablet 1.2 g Cadila (Zydus) Generic now available Minastrin 24 Fe (Warner Chilcott) Ethinyl estradiol/norethindrone acetate/ferrous fumarate Lupin (Mibelas) Generic now available Pataday (Alcon) Olopatadine 0.2% ophthalmic solution Teva Generic now available Prandimet (Novo Nordisk) Repaglinide/metformin tablet Lupin Generic now available Pristiq (Wyeth) Desvenlafaxine succinate extended-release tablet Lupin, Mylan, Teva (Actavis), West-Ward Generic now available Quartette (Teva) Levonorgestrel/Ethinyl estradiol Lupin (Fayosim) Generic now available Relpax (Pfizer) Eletriptan Ajanta, Teva Generic now available Renvela (Genzyme) Sevelamer carbonate (for oral suspension and tablet) Aurobindo Generic now available Sabril (Lundbeck) Vigabatrin for oral solution Par Generic now available Sarafem (Apil) Fluoxetine 10 mg tablet Torrent Generic now available Strattera (Lilly) Atomoxetine Glenmark, Teva Generic now available Tazorac (Allergan) Tazarotene 0.1% cream Taro Generic now available Transderm Scop (GlaxoSmithKline) Scopolamine patch Perrigo Generic now available Vigamox (Alcon) Moxifloxacin ophthalmic solution Apotex, Lupin Generic now available Virazole (Valeant) Ribavirin inhalation solution Zydus (Navinta) Generic now available Vytorin (Merck) Ezetimibe/Simvastatin Impax, Teva Generic now available Zetia (Merck) Ezetimibe Amneal, Apotex, Ohm, Par (Glenmark),Sandoz, Teva Generic now available Cancidas (Merck) Caspofungin Gland, Sandoz September 2017 Herceptin (Roche) Trastuzumab Mylan (biosimilar i ), Celltrion/Teva (biosimilar i ) 100 September Adcirca (Lilly) Tadalafil Aurobindo, Synthon November /7

2 Sustiva (Bristol-Myers Squibb) Viagra (Pfizer) Viread (Gilead) Copaxone (Teva) Efavirenz Sildenafil Tenofovir disoproxil fumarate tablet Glatiramer 40 mg/ml "Tablet: Aurobindo, Cipla, Emcure, Hetero, Macleods, Matrix, Micro Labs, Mylan, Par, Pharmacare, Strides, Teva Capsule: Aurobindo, Cipla, Micro Labs "Ajanta, Amneal, Apotex, Appco, Aurobindo, Dr. Reddy s, Hetero, Macleods, Mylan, Reyoung, Rubicon, Teva Aurobindo, Cipla, InvaGen, Lupin, Macleods, Matrix, Mylan, Pharmacare, Strides Arcolab, Teva December December 2017 (or earlier) 92 December Dr. Reddy s, h,94 Mylan, h,146 Momenta/Novartis, h,146 Sandoz, h,70 others 30 First half ,146 Treximet (Pozen) Sumatriptan/Naproxen Alphapharm, f,102 Dr. Reddy s, Mylan, Par, Teva f,102 February Factive (Cornerstone) Gemifloxacin tablet Orchid March Sensipar (Amgen) Cinacalcet tablet Aurobindo, Mylan, Teva March Enbrel (Amgen) Etanercept Sandoz (biosimilar i ) April 2018 or later 159 Lexiva (Vertex) Fosamprenavir tablet Lupin, Mylan, Ranbaxy f,130 June Remodulin (United Therapeutics) Treprostinil injection Sandoz June 2018 (or earlier) 126 Levitra (GlaxoSmithKline) Vardenafil tablet Macleods, Teva 3 rd quarter Acanya (Valeant) Benzoyl peroxide 2.5%/ Clindamycin phosphate 1.2% Teva July 2018 (or earlier) 87 Ampyra (Acorda) Aloxi (Eisai) Dalfampridine extended-release tablet Palonosetron injection Accord, Alkem, Allergan, f,119 Aurobindo, Mylan, Par, f Roxane, Sun, Teva Akorn, Aurobindo, Dr. Reddy s, Exela, Fresenius Kabi, Sandoz, Sagent, Teva July September 2018 (or earlier) 78 Cialis (Eli Lilly) Tadalafil Alembic, Aurobindo, Sun, Teva September Staxyn (Bayer) Vardenafil orally disintegrating tablet Alembic, Macleods, Par, Teva October ,96 Vesicare (Astellas) Solifenacin succinate Ajanta, Glenmark, Teva October Finacea (Bayer) Azelaic acid gel Glenmark November 2018 Fortesta (Endo) Testosterone gel Teva November 2018 Lyrica (Pfizer) Pregabalin "Capsule: Alembic, Alkem, Apotex, Aurobindo, Lupin, Macleods, Mylan, Sandoz, Teva, Wockhardt Oral solution: Apotex, Lupin, Novel December Rapaflo (Allergan) Silodosin Lupin, Sandoz Before December 2018 e,19 Latuda (Sunovion) Lurasidone Accord, Amneal, Aurobindo, Emcure, InvaGen, Lupin, MSN, Par, Sun, Teva, Zydus January ,135 Zyclara (Medicis) Imiquimod cream Actavis f,17 January 2019 (or earlier) 17 Gilenya (Novartis) Fingolimod Accord, Alkem, Aurobindo, Biocon, Glenmark, MSN, Par, Strides, Teva, Torrent, f,173 Zydus, February /7

3 Ranexa (Gilead) Ranolazine Teva February Solodyn (Medicis) Minocycline extended-release tablet 55 mg, 65 mg, 80 mg, 105 mg, 115 mg Apotex, h,117 Alkem, Aurobindo, Mylan, Sandoz, Sidmak, Sun February AzaSite (InSite Vision) Azithromycin 1% ophthalmic solution Mylan, f,13 Sandoz March 2019 Emend (Merck) Fosaprepitant injection Fresenius Kabi, Sagent, Sandoz March ,90 Faslodex (AstraZeneca) Fulvestrant Sandoz f,144 March 2019 (or earlier) 144 Exjade (Novartis) Deferasirox tablets for oral suspension Actavis Elizabeth, Mylan h,11 Before April 2019 e,43 Canasa (Aptalis) Mesalamine rectal suppository 1 g Mylan, Renaissance, Sandoz, Zydus June 2019 (or earlier) 133 Sporanox (Janssen) Itraconazole solution Fera h,45 June 2019 (or earlier d ) Uloric (Takeda) Febuxostat Alembic, Dr. Reddy s, h,97 Hetero, h,97 Lupin, Macleods, Mylan, Ranbaxy, h,97 Roxane, Sun h,97 June ,47 Ziagen (Viiv) Abacavir oral solution Camber (Hetero) August 2019 (or earlier d ) 21 Edluar (Orexo) Zolpidem sublingual tablet Mylan, Par September ,155 Zubsolv (Orexo) Buprenorphine/Naloxone sublingual tablet Actavis f,84 September Treanda (Teva) Bendamustine 25 mg/vial and 100 mg/vial Accord, Apotex, Breckinridge, Glenmark, Hospira, InnoPharma, Sagent, f,107 Wockhardt November 2019 (or earlier) 111 Daliresp (AstraZeneca) Roflumilast Apotex, h,72 Hetero, Mylan, Strides Pharma, others 72 January 2020 (or earlier d ) 72,156 Namenda XR (Forest) Memantine extended-release capsule Amneal, Anchen, Apotex, Lupin, Macleods, Mylan, Sun, Teva, f,58 Wockhardt, h,118 Zydus January Silenor (Somaxon) Doxepin tablet Actavis, Mylan, Par, Zydus January 2020 (or earlier) 39 Delzicol (Warner Chilcott) Mesalamine delayed-release capsule Cadila, f,139 Mylan, h,115 Zydus f,109 March 2020 (or earlier) 109,139 Safyral (Bayer) Drospirenone/Ethinyl estradiol/levomefolate calcium Teva April 2020 (or earlier ) Chantix (Pfizer) Varenicline Apotex, Mylan, Teva May 2020 (or earlier d ) 49 Dexilant (Takeda) Dexlansoprazole Impax, f,104 Par, TWi f,93 June Avelox (Bayer) Moxifloxacin 0.8% IV solution Mylan July 2020 (earlier d ) 21 Desonate (Bayer) Desonide 0.05% gel Teresina August 2020 (or earlier d ) 21 Kuvan (BioMarin) Sapropterin Dr. Reddy s, f,91 Par October 2020 (or earlier) 161 Absorica (Ranbaxy) Isotretinoin Actavis f,88 December 2020 (or earlier) 88 Ofirmev (Mallinckrodt) Acetaminophen injection Custopharm (Perrigo), Sandoz December 2020 (or earlier) 31 Sutent (Pfizer) Sunitinib Mylan February 2021 Jevtana (Sanofi Aventis) Cabazitaxel Accord, Actavis, Apotex, BPI, h,122 Breckenridge, h,54 Dr. Reddy s, h,121 Fresenius Kabi, h,170 Sandoz March 2021 (or earlier d ) 151 Tarceva (OSI) Erlotinib Apotex May 2021 (or earlier d ) 76 3/7

4 Diclegis (Duchesnay) Doxylamine/Pyridoxine Actavis Before June 2021 e,158 Perforomist (Mylan) Formoterol inhalation solution Teva June 2021 Selzentry (Pfizer) Maraviroc Hetero, Sandoz August 2021 (or earlier d ) 21 Bystolic (Forest) Nebivolol Actavis, f,67 Alkem, f,67 Amerigen, f,67 Glenmark, f,63,67 Hetero, f,67 Indchemie, f,67 Torrent f,67 September 2021 (or earlier) 67 Atripla (Gilead) Efavirenz/Emtricitabine/Tenofovir disoproxil fumarate Aurobindo, Cipla, Hetero, Macleods, Matrix, Teva Before September 2021 e,10,68 Emtriva (Gilead) Emtricitabine capsule Aurobindo, Cipla, Matrix September 2021 (or earlier d ) 4 Truvada (Gilead) Emtricitabine/Tenofovir disoproxil fumarate tablet Aurobindo, Cipla, Hetero, Lupin, f,25 Matrix, Mylan, h,25 Strides Arcolab, Teva Before September 2021 e,112 Brovana (Sunovion) Arformoterol Cipla, Teva November 2021 (or earlier d ) 21 Pradaxa (Boehringer Ingelheim) Dabigatran Alembic, Glenmark, Hetero, h,44 Teva December 2021(or earlier d ) 44 Velcade (Millennium) Bortezomib Accord, Apotex, Fresenius Kabi, Hospira, Pharmascience, Teva Revlimid (Celgene) Lenalidomide Allergan f,23 March Vimpat (UCB) Lacosamide "Tablet: Accord, Alembic, Amneal, Aurobindo, Glenmark, MSN, Mylan, Sun, Teva Oral solution: Amneal, Apotex, Glenmark January 2022 (or earlier d ) 125 March Zipsor (Depomed) Diclofenac potassium liquid-filled capsule Actavis, f,95 Bionpharma March 2022 (or earlier) 95 Alimta (Lilly) Pemetrexed Accord, Apotex, APP, Emcure, h,69 Heritage, h,69 Hospira, Qilu, Sandoz, h,56 Teva May 2022 (or earlier d ) Banzel (Eisai) Rufinamide Glenmark, Hetero, h,80 Lupin, f,145 Mylan, Roxane, h,80 West-Ward May 2022 (or earlier) 48 Vimovo (Horizon) Naproxen/Esomeprazole magnesium delayed-release tablet Actavis, h,77 Dr. Reddy s, Lupin, f,77 Mylanh, 77 May 2022 (or earlier d ) 77 Viibryd (Forest) Vilazodone Accord, Alembic, Ivagen, h,2 Teva June 2022 (or earlier d ) Janumet (Merck) Sitagliptin/Metformin Apotex, Sandoz, Teva, Zydus July 2022 (or earlier d ) 21,124 Janumet XR (Merck) Sitagliptin/Metformin extended- release tablet Anchen, Teva July 2022 (or earlier d ) 21,124 Januvia (Merck) Sitagliptin Apotex, Mylan, Sandoz, Sun, Teva July 2022 (or earlier d ) 21,124 Toviaz (Pfizer) Fesoterodine extended-release tablet Accord, f,108,141 Alembic, Amerigen, Amneal, Aurobindo, Cadila, f,108,141 Dr. Reddy s, Impax, f,108,141 Mylan, h,141,147 Lupin, Sandoz, Sun, Teva, Wockhardt, h,82 Zydus f,108,141 July 2022 (or earlier d ) 82,141,147 Folotyn (Spectrum) Pralatrexate Teva November Rayos (Horizon) Prednisone delayed-release tablet Teva December 2022 (or earlier) 36 Humira (AbbVie) Adalimumab Amgen (biosimilar i ), Boehringer Ingelheim (biosimilar i ) 26 January Vyvanse (Shire) Lisdexamfetamine Actavis, Amneal, Mylan, Roxane, Sandoz February Epiduo Forte (Galderma) Adapalene 0.3%/Benzoyl peroxide 2.5% Taro March 2023 (or earlier d ) 21 4/7

5 Suprep (Braintree) Magnesium sulfate anhydrous, potassium sulfate, sodium sulfate Novel, Paddock (Perrigo), Breckenridge f,174 March Edurant (Janssen) Rilpivirine Strides Arcolab April Livalo (Kowa) Pitavastatin Aurobindo, Lupin, Mylan, h,138 Orient, Sawai, Zydus f,136 May 2023 (or earlier) 136 Gralise (Depomed) Gabapentin Incepta, f,98 Zydus, f,98 Teva January 2024 (or earlier) 62,98 Bepreve (Bausch and Lomb) Bepotastine 1.5% ophthalmic solution Sandoz September 2024 (or earlier d ) 21 Fentora (Cephalon [Teva]) Fentanyl citrate buccal tablet Impax, f,57 Mylan, f,89 Sandoz, f,106 Before December 2024 e,57 Namzaric (Forest) Donepezil/Memantine Amneal January Nucynta (Depomed) Tapentadol tablet Tablet: Alkem, Roxane, Teva Oral solution: Teva June Nucynta ER (Depomed) Tapentadol extended-release tablet Teva, West-ward June Qsymia (Vivus) Phentermine/Topiramate extended-release capsule Dr. Reddy s, f Teva h,41 June 2025 (or earlier e ) 46 Xyrem (Jazz) Sodium oxybate Amneal, Ohm, Par, h,7 Ranbaxy, f,143 Roxane (West-Ward), Sun, f,153 Wockhardt f,143 December Sprycel (Bristol-Myers Squibb) Dasatinib Apotex Before March 2026 e,152 Afinitor (Novartis) Everolimus Breckenridge, h,148 Par, West-Ward May 2026 (or earlier d ) 148 Natazia (Bayer) Dienogest/estradiol valerate Lupin, h,61 Teva May 2026 (or earlier d ) 61,165 Aplenzin (Valeant) Bupropion hydrobromide extended-release tablet Teva, Paddock, h,105 Par f,83 Before June 2026 e,38,83 Cambia (Depomed) Diclofenac potassium oral solution 50 mg Par Before June 2026 e,150 Nuedexta (Avanir) Dextromethorphan/Quinidine Impax, f,116 Par, Sandoz, f,103 Wockhardt f,85 July 2026 (or earlier) 85,103 Dymista (Meda) Azelastine and fluticasone nasal spray Apotex August 2026(or earlier d ) 21 AndroGel 1.62% (AbbVie) Testosterone Perrigo, Teva October 2026 (or earlier) e,166 Saphris (Forest) Asenapine Alembic October 2026 (or earlier d ) 21 Prezista (Janssen) Darunavir tablet Cipla, Hetero, Lupin, Mylan, Teva Before February Aveed (Endo) Testosterone undecanoate Paddock f,176 March Tradjenta (Boehringer Ingelheim) Linagliptin Aurobindo May 2027 (or earlier d ) 120 Lumigan (Allergan) Bimatoprost ophthalmic solution 0.01% Actavis, f,123 Apotex, Hi-Tech, f,123 Lupin, f,123 Sandoz June Travatan Z (Alcon) Travoprost 0.004% ophthalmic solution Apotex, Mylan, Par Before September Fanapt (Vanda) Iloperidone Inventia, Roxane f,157 November Nexavar (Bayer) Sorafenib Mylan December 2027 (or earlier d ) 21 Oracea (Galderma) Doxycycline 40 mg capsule Amneal, Lupin, Mylan December /7

6 Promacta (Novartis) Eltrombopag Hetero February 2028 (or earlier d ) 21 Prepopik (Ferring) Citric acid, magnesium oxide, sodium picosulfate Par October Onglyza (Bristol-Myers Squibb) Saxagliptin Amneal, Aurobindo, Glenmark, Par, Teva h,99 November 2028 (or earlier d ) Pennsaid (Horizon) Diclofenac sodium 2% solution Amneal, Lupin, Perrigo (Paddock), Taro, Teva January 2029 (or earlier) 66 Colcrys (Takeda) Colchicine Hikma, h,42 Par, Teva Lo Loestrin Fe (Actavis) Ethinyl estradiol/norethindrone acetate/ferrous fumarate Tygacil (Wyeth) Tigecycline injection Fresenius Kabi, Sandoz February 2029 (or earlier e ) 64 (authorized generic available) Glenmark, Jai (Mylan) February 2029 (or earlier e ) 32 February (authorized generic available) Isentress (Merck) Raltegravir tablet Hetero March 2029 (or earlier d ) 21 Brisdelle (Noven) Paroxetine mesylate 7.5 mg capsule Prinston, Teva April 2029 (or earlier d ) 9 Moxeza (Alcon) Moxifloxacin ophthalmic solution Lupin, Teva May 2029 (or earlier e ) 6 Onexton (Dow) Savella (Forest) Benzoyl peroxide 3.75%/ Clindamycin phosphate 1.2% Milnacipran Actavis/Teva, h,28 Allergan, h,113 Perrigo, h,12 Taro Amneal, Apotex, f,14 First Time US Generics, h,167 Glenmark, Hetero, h,168 Lupin, Mylan, Par, Ranbaxy, h,168 Sandoz h,52 August 2029 (or earlier) d September 2029 (or earlier) 127 (may be authorized generic) 127 Tykerb (Novartis) Lapatinib Natco September 2029 (or earlier d ) 21 Suboxone (Reckitt Benckiser) Buprenorphine/Naloxone sublingual film Par, h,169 Teva, h,86 March 2030 (or earlier d ) Relistor (Salix) Methylnaltrexone 12 mg/0.6 ml subcutaneous injection Mylan December 2030 (or earlier d ) 21 Giazo (Valeant) Balsalazide 1.1 g tablet Apotex, h,129 Lupin, Mylan, Par June 2031 (or earlier e ) 75 Mirvaso (Galderma) Brimonidine tartrate gel Perrigo June 2031 (or earlier d ) 53 Multaq (Sanofi-Aventis) Dronedarone Amneal, Alkem, Glenmark, Unimark, h,134 Teva June 2031 (or earlier d ) 134 Contrave (Orexigen) Bupropion/Naltrexone sustained release tablet Actavis h,114 January 2032 (or earlier d ) 114 Xartemis XR (Mallinckrodt) Oxycodone/acetaminophen extended-release tablet Teva May 2032 (or earlier, but not before June 2020 d ) 172 Zohydro (Pernix) Hydrocodone extended-release capsule Alvogen, Teva September Acticlate (Aqua) Doxycycline hyclate tablet 75 mg, 150 mg Mayne Uncertain g Advair Diskus (GlaxoSmithKline) Fluticasone/salmeterol None (Mylan and West-Ward have filed for approval) 73,101 Uncertain g,142 Alocril (Allergan) Nedocromil ophthalmic Akorn Uncertain g Avandamet (SB Pharmco) Rosiglitazone/Metformin Teva Avandaryl (SB Pharmco) Rosiglitazone/Glimepiride Teva Uncertain 27 (brand Uncertain 27 (brand 6/7

7 Avandia (SB Pharmco) Rosiglitazone Mylan, Dr. Reddy s, Roxane, Sandoz, Teva, Hikma Uncertain 27 Differin (Galderma) Adapalene topical solution 0.1% Call (Rochester) Exelon (Novartis) Rivastigmine oral solution Ranbaxy (Sun) Kaletra (Abbott) Lopinavir/Ritonavir Tablet: Aurobindo, Cipla, Hetero, Matrix, Macleods, Mylan Oral solution: Cipla, Silarx Uncertain g (brand Uncertain g (brand Uncertain 137 Liptruzet (Merck) Atorvastatin/Ezetimibe Teva Uncertain g Norvir (Abbvie) Ritonavir 100 mg tablet Aurobindo, Cipla, Mylan, Hetero, West-Ward Oxytrol (Allergan) Oxybutynin transdermal patch Teva Uncertain 37 ProAir HFA (Teva) Albuterol Perrigo f,34 Uncertain 34 Renagel (Genzyme) Sevelamer hydrochloride (oral suspension)(brand not available) Impax f,15 Uncertain (sometime in 2017 or 2018) 137 Uncertain (brand Reyataz (Bristol-Myers Squibb) Atazanavir capsule Aurobindo, Emcure, Matrix, Pharmacare, Teva Uncertain 83 Rezira (Hawthorn) Hydrocodone/pseudoephedrine oral solution Mayne, Tris Pharma, Perrigo (Paddock) Uncertain g Topicort (Taro) Desoximetasone 0.25% spray Perrigo Uncertain g Vituz (Cypress) Hydrocodone bitartrate/ chlorpheniramine maleate Acella, Tris Uncertain g Welchol (Daiichi Sankyo) Colesevelam tablet and oral suspension Impax, f,22 Actavis, h,71 Glenmark, f,59 Uncertain 22,59 7/7

ESTIMATED LAUNCH DATE* Sensipar cinacalcet Amgen Mar 2018 Endocrine Disorders High. Altoprev lovastatin ER Andrx Mar 2018 High Blood Cholesterol Low

ESTIMATED LAUNCH DATE* Sensipar cinacalcet Amgen Mar 2018 Endocrine Disorders High. Altoprev lovastatin ER Andrx Mar 2018 High Blood Cholesterol Low Topicort 0.25% Topical Spray desoximetasone topical spray Taro Mar 2018 Skin Sensipar cinacalcet Amgen Mar 2018 Endocrine Disorders High Altoprev lovastatin ER Andrx Mar 2018 High Blood Cholesterol Ketek

More information

OptumRx generic pipeline forecast

OptumRx generic pipeline forecast OptumRx generic pipeline forecast 2017 Daytrana methylphenidate Noven Therapeutics Transdermal patch All 2017+ Epiduo adapalene/benzoyl peroxide Endo Gel All 2017+ Norvir ritonavir AbbVie Capsule; tablet

More information

Anticipated Availability of First-Time Generics

Anticipated Availability of First-Time Generics This Clinical Resource gives subscribers additional insight related to the Recommendations published in October 2017 ~ Resource #331042 Anticipated Availability of First-Time Generics To help explain the

More information

NEW PATENTED MEDICINES REPORTED TO PMPRB 2011 (UPDATE AS OF NOVEMBER 30, HIGHLIGHTED)

NEW PATENTED MEDICINES REPORTED TO PMPRB 2011 (UPDATE AS OF NOVEMBER 30, HIGHLIGHTED) HUMAN DRUGS NEW PATENTED MEDICINES REPORTED TO PMPRB 2011 COMPANY BRAND NAME CHEMICAL NAME DIN THERAPEUTIC USE DATE OF FIRST SALE Abbott Laboratories Limited Norvir 100 mg/tablet ritonavir 02357593 HIV

More information

Recommended comparator products: Medicines for HIV/AIDS and related diseases

Recommended comparator products: Medicines for HIV/AIDS and related diseases Recommended comparator products: Medicines for HIV/AIDS and related diseases Comparator products should be purchased from a well regulated market with stringent regulatory authority 1. Invited medicinal

More information

2014 DTC National Advertising Awards Finalists

2014 DTC National Advertising Awards Finalists 2014 DTC National Advertising Awards Finalists All Gold, Silver, and Bronze winners will be announced at the DTC National Advertising Awards Dinner on April 23. Each therapeutic category winner from Television,

More information

Information for Vermont Prescribers of Prescription Drugs Long Form

Information for Vermont Prescribers of Prescription Drugs Long Form Information for Vermont Prescribers of Prescription Drugs Long Form Pylera (bismuth subcitrate potassium, metronidazole, and tetracycline hydrochloride) Capsules The prices listed below are Average Wholesale

More information

Information for Vermont Prescribers of Prescription Drugs Long Form Fetzima (levomilnacipran) Extended Release Capsules

Information for Vermont Prescribers of Prescription Drugs Long Form Fetzima (levomilnacipran) Extended Release Capsules Information for Vermont Prescribers of Prescription Drugs Long Form Fetzima (levomilnacipran) Extended Release Capsules The prices listed below are Average Wholesale Prices ( AWP ) as established and made

More information

Medication and Dose 10/04/ /05/2016 Total % Change Since 10/2012 ABILIFY 10 MG TABLET $18.76 $ %

Medication and Dose 10/04/ /05/2016 Total % Change Since 10/2012 ABILIFY 10 MG TABLET $18.76 $ % Table Comparing NADAC prices for select brand name prescription medications on October 4, 2012 and October 5, 2016 to show how much prices have gone up for these medications. These medications increased

More information

OptumRx generic pipeline forecast

OptumRx generic pipeline forecast OptumRx generic pipeline forecast 2017 DAYTRANA Noven Therapeutics methylphenidate Transdermal patch All 2017 NORVIR AbbVie ritonavir Capsule; tablet All 2017 PROVENTIL HFA Merck albuterol sulfate Inhalation

More information

OptumRx generic pipeline forecast

OptumRx generic pipeline forecast OptumRx generic pipeline forecast 2018 DAYTRANA methylphenidate Noven Therapeutics Transdermal patch All 2018 NORVIR ritonavir AbbVie Capsule; tablet All 2018 PROVENTIL HFA albuterol sulfate Merck Inhalation

More information

TECHNICAL APPENDIX: A PERSPECTIVE ON PRESCRIPTION DRUG COPAYMENT COUPONS

TECHNICAL APPENDIX: A PERSPECTIVE ON PRESCRIPTION DRUG COPAYMENT COUPONS TECHNICAL APPENDIX: A PERSPECTIVE ON PRESCRIPTION DRUG COPAYMENT COUPONS METHODS FOR DETERMINING COPAY COUPON STATUS The copay coupon information comes from www.internetdrugcoupons.com (IDC). These data

More information

Information for Vermont Prescribers of Prescription Drugs Tradjenta (linagliptin) and Jentadueto (linagliptin+metformin) Tablets

Information for Vermont Prescribers of Prescription Drugs Tradjenta (linagliptin) and Jentadueto (linagliptin+metformin) Tablets Information for Vermont Prescribers of Prescription Drugs Tradjenta (linagliptin) and Jentadueto (linagliptin+metformin) Tablets This list does not imply that the products on this chart are interchangeable

More information

Recommended Comparator Products: Medicines for HIV/AIDS and Related Diseases

Recommended Comparator Products: Medicines for HIV/AIDS and Related Diseases Medicines for HIV/AIDS and Related Diseases Comparator products should be purchased from a well-regulated market with a stringent regulatory authority. 1 Invited medicinal products Abacavir, 60 mg, 300

More information

REGULATORY UPDATES: APPROVAL, DENIALS AND AGREEMENTS REGULATORY UPDATES: APPROVAL, (CONTINUED)... 38

REGULATORY UPDATES: APPROVAL, DENIALS AND AGREEMENTS REGULATORY UPDATES: APPROVAL, (CONTINUED)... 38 CHAPTER ONE: INTRODUCTION... 1 STUDY OBJECTIVES... 1 REASONS FOR DOING THIS STUDY... 1 INTENDED AUDIENCE... 2 SCOPE OF THE STUDY... 2 METHODOLOGY... 2 INFORMATION SOURCES... 2 ABOUT THE AUTHOR... 3 RELATED

More information

Information for Vermont Prescribers of Prescription Drugs

Information for Vermont Prescribers of Prescription Drugs Information for Vermont Prescribers of Prescription Drugs ZOLOFT (sertraline hydrochloride) tablets, for oral use This list does not imply that the products on this chart are interchangeable or have the

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL Notification of of Medicines MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965)

More information

Information for Vermont Prescribers of Prescription Drugs

Information for Vermont Prescribers of Prescription Drugs Information for Vermont Prescribers of Prescription Drugs ARTHROTEC (diclofenac sodium/misoprostol) tablets This list does not imply that the products on this chart are interchangeable or have the same

More information

Mercy Care Plan. Acyclovir Ointment. Products Affected. acyclovir ointment 5 % external Details. Criteria. Requires use of oral Acyclovir

Mercy Care Plan. Acyclovir Ointment. Products Affected. acyclovir ointment 5 % external Details. Criteria. Requires use of oral Acyclovir Acyclovir Ointment Mercy Care Plan acyclovir ointment 5 % external Requires use of oral Acyclovir 1 Adcirca ADCIRCA TABLET 20 MG ORAL Requires use of Sildenafil 2 Albenza ALBENZA TABLET 200 MG ORAL Requires

More information

Aetna Better Health of Illinois Medicaid Formulary Updates

Aetna Better Health of Illinois Medicaid Formulary Updates October 2017 o DOXYLAMINE SUCCINATE 25mg-QL o DULOXETINE CAP 40MG DR-QL o GUANFACIN ER TABS (all strengths)-ql o TOBRAMYCIN NEBU SOLUTION- PA August 2017 Aetna Better Health of Illinois Medicaid 2017 Formulary

More information

Acyclovir Ointment. Aetna Better Health Pennsylvania. Products Affected. acyclovir ointment 5 % external Details. Criteria

Acyclovir Ointment. Aetna Better Health Pennsylvania. Products Affected. acyclovir ointment 5 % external Details. Criteria Medications that require Step Therapy (ST) require trial and failure of preferred formulary agents prior to their authorization. If the prerequisite medications have been filled within the specified time

More information

Superior Select Health Plans: Tribute-1 Tier May 2018 Formulary Addendum

Superior Select Health Plans: Tribute-1 Tier May 2018 Formulary Addendum Superior Select Health Plans: Tribute-1 Tier May 2018 Formulary Addendum Below is a list formulary changes for the benefit year 2018. This is not a complete list of drugs covered by the Part D plan. The

More information

Step Therapy Requirements

Step Therapy Requirements An Independent Licensee of the Blue Cross and Blue Shield Association Step Therapy Requirements Effective: 12/01/2017 Updated 11/2017 H0302_2_2014 CMS Accepted 05/05/2014 1 ABILIFY Abilify 10 mg tablet

More information

Information for Vermont Prescribers of Prescription Drugs

Information for Vermont Prescribers of Prescription Drugs Information for Vermont Prescribers of Prescription Drugs ARTHROTEC (diclofenac sodium/misoprostol) tablets This list does not imply that the products on this chart are interchangeable or have the same

More information

Estimated dates are subject to change due to patent litigation, additional patents, exclusivities

Estimated dates are subject to change due to patent litigation, additional patents, exclusivities Estimated dates are subject to change due to patent litigation, Estimated Dates of Possible First Time Generic/ Rx-to-OTC Market Entry Uroxatral alfuzosin extendedrelease Benign prostatic hyperplasia Anzemet

More information

Notice of Mid-Year Changes to 2019 Paramount Enhanced Formulary

Notice of Mid-Year Changes to 2019 Paramount Enhanced Formulary Notice of Mid-Year s to 2019 Paramount Enhanced Formulary Paramount Elite (HMO) may immediately remove a brand name drug on our List if we are replacing it with a new generic drug that will appear on the

More information

Mercy Care ALBENDAZOLE. Products Affected. ALBENZA TABLET 200 MG ORAL Details. Criteria. Refer to PA Guideline for approval criteria

Mercy Care ALBENDAZOLE. Products Affected. ALBENZA TABLET 200 MG ORAL Details. Criteria. Refer to PA Guideline for approval criteria ALBENDAZOLE Mercy Care ALBENZA TABLET 200 MG ORAL Refer to PA Guideline for approval criteria 1 BRIMONIDINE-TIMOLOL COMBIGAN SOLUTION 0.2-0.5 % OPHTHALMIC Requires use of separate ingredients for at least

More information

Step Therapy Requirements

Step Therapy Requirements An Independent Licensee of the Blue Cross and Blue Shield Association Step Therapy Requirements Effective: 05/01/2018 Updated 4/2018 H0302_2_2014 CMS Accepted 05/05/2014 1 BETA-BLOCKERS BYSTOLIC 10 MG

More information

Information for Vermont Prescribers of Prescription Drugs

Information for Vermont Prescribers of Prescription Drugs Information for Vermont Prescribers of Prescription Drugs LIPITOR (atorvastatin calcium) tablets This list does not imply that the products on this chart are interchangeable or have the same efficacy or

More information

US pharmaceutical market: trends, issues, forecast. Doug Long Vice President Industry Relations IMS Health

US pharmaceutical market: trends, issues, forecast. Doug Long Vice President Industry Relations IMS Health US pharmaceutical market: trends, issues, forecast Doug Long Vice President Industry Relations IMS Health 2006 Strategic management review The World Pharmaceutical Market All reproduction rights, quotations,

More information

Information for Vermont Prescribers of Prescription Drugs. Lunesta (eszopiclone tablets)

Information for Vermont Prescribers of Prescription Drugs. Lunesta (eszopiclone tablets) Information for Vermont Prescribers of Prescription Drugs Lunesta (eszopiclone tablets) This list does not imply that the products on this chart are interchangeable or have the same efficacy or safety.

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 42/2.5/0453 ZYDUS HEALTHCARE

More information

Information for Vermont Prescribers of Prescription Drugs DUZALLO (lesinurad and allopurinol) Tablets

Information for Vermont Prescribers of Prescription Drugs DUZALLO (lesinurad and allopurinol) Tablets Information for Vermont Prescribers of Prescription Drugs DUZALLO (lesinurad and allopurinol) Tablets This list does not imply that the products on this chart are interchangeable or have the same efficacy

More information

FORMULARY UPDATES TO DENVER HEALTH MEDICAID CHOICE (DHMC) AND CHILD HEALTH PLAN PLUS (CHP+) PLANS

FORMULARY UPDATES TO DENVER HEALTH MEDICAID CHOICE (DHMC) AND CHILD HEALTH PLAN PLUS (CHP+) PLANS FORMULARY UPDATES TO DENVER HEALTH MEDICAID CHOICE (DHMC) AND CHILD HEALTH PLAN PLUS (CHP+) PLANS DHMC/CHP+ may add or remove drugs from the formulary or make changes to restrictions on formulary drugs

More information

Information for Vermont Prescribers of Prescription Drugs

Information for Vermont Prescribers of Prescription Drugs Information for Vermont Prescribers of Prescription Drugs CADUET (amlodipine besylate/atorvastatin calcium) tablets This list does not imply that the products on this chart are interchangeable or have

More information

J Jubilant Pharma Group, catering to Dosage

J Jubilant Pharma Group, catering to Dosage DOSAGE FORMULATIONS Jubilant Generics, is one of the business arms of J Jubilant Pharma Group, catering to Dosage Formulations (DF) & Active Pharmaceutical Ingredients (API) business segment across developed

More information

TRICARE Uniform Formulary. Pre-Authorization Requirements

TRICARE Uniform Formulary. Pre-Authorization Requirements TRICARE Uniform Formulary Pre-Authorization Requirements The Department of Defense (DoD) requires pre-authorization on select medications. These medications are on the DoD s pre-authorization list because

More information

High-Cost Drug Exclusions

High-Cost Drug Exclusions Pharmacy Services High-Cost Exclusions The high cost medications listed below are excluded from coverage because lower cost similar alternatives are available. To help you get the best health benefit at

More information

CONTACT POLPHARMA GROUP POLPHARMA B2B

CONTACT POLPHARMA GROUP POLPHARMA B2B DOSSIER FDFLIST Product name Pharmaceutical form Strength Reference Therapeutic class ALIMENTARY TRACT & METABOLISM 1. Esomeprazole sodium or injection 40 mg Nexium / AstraZeneca Antiulcerant 2. Omeprazole

More information

Pharmacy and Therapeutics (P&T) Committee Provider Update

Pharmacy and Therapeutics (P&T) Committee Provider Update Pharmacy and Therapeutics (P&T) Committee Provider Update THIRD QUARTER 2017 Presbyterian Health Plan, Inc. Presbyterian Insurance Company, Inc. P&T Committee Decisions Effective August 15, 2017 Dear Healthcare

More information

2015 Step Therapy Prior Authorization Medical Necessity Guidelines

2015 Step Therapy Prior Authorization Medical Necessity Guidelines Tufts Health Unify 2015 Step Therapy Prior Authorization Medical Necessity Guidelines Effective: 01/01/2015 Updated: 10/01/2015 Tufts Health Plan P.O. Box 9194 Watertown, MA 02471-9194 Phone: 855-393-3154

More information

Information for Vermont Prescribers of Prescription Drugs

Information for Vermont Prescribers of Prescription Drugs Information for Vermont Prescribers of Prescription Drugs Otezla (apremilast) Tablets -- This list does not imply that the products on this chart are interchangeable or have the same efficacy or safety.

More information

Managing the Unmanageable

Managing the Unmanageable Managing the Unmanageable Controlling Costs in an Explosive Rx Environment Presented by: Dick Bullard, RPh, SVP Pharmacy Darryl Martin, VP of Sales A Unique Vision of Care Magellan Health is a healthcare

More information

FORMULARY UPDATES TO DENVER HEALTH MEDICAID CHOICE (DHMC) AND CHILD HEALTH PLAN PLUS (CHP+) PLANS

FORMULARY UPDATES TO DENVER HEALTH MEDICAID CHOICE (DHMC) AND CHILD HEALTH PLAN PLUS (CHP+) PLANS FORMULARY UPDATES TO DENVER HEALTH MEDICAID CHOICE (DHMC) AND CHILD HEALTH PLAN PLUS (CHP+) PLANS DHMC/CHP+ may add or remove drugs from the formulary or make changes to restrictions on formulary drugs

More information

Drug Pipeline Monthly Update

Drug Pipeline Monthly Update Drug Pipeline Monthly Update Critical updates in an ever changing environment June 2017 New drug information Baxdela (delafloxacin): The Food and Drug Administration (FDA) approved Melinta s Baxdela, a

More information

HIV MEDICATIONS AT A GLANCE. Atripla 600/200/300 mg tablet tablet daily. Complera 200/25/300 mg tablet tablet daily

HIV MEDICATIONS AT A GLANCE. Atripla 600/200/300 mg tablet tablet daily. Complera 200/25/300 mg tablet tablet daily HIV MEDICATIONS AT A GLANCE Generic Name Trade Name Strength DIN Usual Dosage Single Tablet Regimen (STR) Products Efavirenz/ Emtricitabine/ rilpivirine/ elvitegravir/ cobicistat/ alafenamide Emtricitabine/

More information

Information for Vermont Prescribers of Prescription Drugs Long Form Bystolic (nebivolol) Tablets

Information for Vermont Prescribers of Prescription Drugs Long Form Bystolic (nebivolol) Tablets Information for Vermont Prescribers of Prescription Drugs Long Form Bystolic (nebivolol) Tablets The prices listed below are Average Wholesale Prices ( AWP ) as established and made available to the public

More information

PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES

PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Generic Additions These generic drugs recently became available in the marketplace. When these generic drugs became available, we began covering them at the

More information

Information for Vermont Prescribers of Prescription Drugs

Information for Vermont Prescribers of Prescription Drugs Information for Vermont Prescribers of Prescription Drugs Otezla (apremilast) Tablets -- This list does not imply that the products on this chart are interchangeable or have the same efficacy or safety.

More information

Drugs in Focus The early bird catches the worm! Selection of novel, still patented APIs for development activities in patent free countries

Drugs in Focus The early bird catches the worm! Selection of novel, still patented APIs for development activities in patent free countries Drugs in Focus The early bird catches the worm! Selection of novel, still patented APIs for development activities in patent free countries Searching for patent circumventing manufacturing processes, polymorphic

More information

TechRX Clinical News Update INDUSTRY NEWS. In This Issue: Industry News Product Highlight Clinical Updates. Second Quarter 2013

TechRX Clinical News Update INDUSTRY NEWS. In This Issue: Industry News Product Highlight Clinical Updates. Second Quarter 2013 TechRX Clinical News Update Second Quarter 2013 In This Issue: Industry News Product Highlight Clinical Updates INDUSTRY NEWS Interesting developments in the Opioid drug category The FDA withheld Purdue

More information

Medicines availability short-term supply issues Last updated 01/05/18

Medicines availability short-term supply issues Last updated 01/05/18 Short-term supply issues This resource includes availability information on medicines that are reported to have supply issues, with next expected availability within the next three months. This list is

More information

RESULTS AND DISCUSSION

RESULTS AND DISCUSSION RESULTS AND DISCUSSION 203 4.1 General Introduction: The researcher has collected both the primary and secondary data. The primary data is collected by direct interaction by using formal questionnaire

More information

High-Cost Drug Exclusions

High-Cost Drug Exclusions PHARMACY SERVICES High-Cost Exclusions The high cost medications listed below are excluded from coverage because lower cost similar alternatives are available. To help you get the best health benefit at

More information

Drug Formulary Update, April 2017 Commercial and State Programs

Drug Formulary Update, April 2017 Commercial and State Programs Drug Formulary Update, April 2017 Commercial and State Programs Updates to the HealthPartners Commercial and State Program Drug Formularies are listed below. Updates apply to all Commercial groups (PreferredRx,

More information

Plan Year CCHP Senior Program (HMO) Step Therapy Criteria (ST)

Plan Year CCHP Senior Program (HMO) Step Therapy Criteria (ST) Plan Year 2016 CCHP Senior Program (HMO) Step Therapy Criteria (ST) Step Therapy: In some cases, CCHP Senior Program (HMO) requires you to first try certain drugs to treat your medical condition before

More information

2014 Preferred Drug List An evidence-based pharmacy program that works for you

2014 Preferred Drug List An evidence-based pharmacy program that works for you 2014 Preferred Drug List An evidence-based pharmacy program that works for you What is the Moda Health Preferred Drug Program? The Moda Health Preferred Drug Program is a pharmacy program that is designed

More information

DOSSIER LIST. tlo_seledyn.pdf :38:01 CMY K CM MY CY

DOSSIER LIST. tlo_seledyn.pdf :38:01 CMY K CM MY CY tlo_seledyn.pdf 1 22.08.2017 14:38:01 C M Y CM MY CY CMY K DOSSIER LIST AVAILABLE DOSSIERS THERAPEUTIC CLASS / MAIN INDICATION LACTOSE FREE ZONE IV CPP FEASIBILITY ALIMENTARY TRACT & METABOLISM 1. Esomeprazole

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: Step Therapy Reference Number: HIM.PA.109 Effective Date: 08.01.17 Last Review Date: 05.18 Line of Business: Health Insurance Marketplace Revision Log See Important Reminder at the end

More information

Quality of medicines in Portugal: a retrospective review of medicine recalls ( ) Ana Teresa Reis Bruna Berardo Rui Loureiro

Quality of medicines in Portugal: a retrospective review of medicine recalls ( ) Ana Teresa Reis Bruna Berardo Rui Loureiro Quality of medicines in Portugal: a retrospective review of medicine recalls (2005-2015) Ana Teresa Reis Bruna Berardo Rui Loureiro Introduction Human medicines Cosmetics Veterinary medicines Medical devices

More information

5-ASA. Products Affected Dipentum 250 mg capsule. Details. Lialda 1.2 gram tablet,delayed release

5-ASA. Products Affected Dipentum 250 mg capsule. Details. Lialda 1.2 gram tablet,delayed release 5-ASA Dipentum 250 mg capsule Lialda 1.2 gram tablet,delayed release You are required to have previous therapy with balsalazide, Delzicol, Apriso, or Asacol HD before we will cover Lialda or Dipentum.

More information

2014 Quantity Limits (QL) Criteria

2014 Quantity Limits (QL) Criteria 2014 Quantity Limits (QL) Criteria Certain drugs covered through your EmblemHealth Medicare HMO/PPO Medicare Plan are covered for only a limited quantity. We do this to ensure compliance with the US Food

More information

CONTRACT UPDATE July 20, 2012

CONTRACT UPDATE July 20, 2012 CONTRACT UP July 20, 2012 ADDS AMPHETAMINE SALT MIX ER CAPSULE 10MG 100 002-3059-11 $422.45 ACTAVIS ADDS AMPHETAMINE SALT MIX ER CAPSULE 20MG 100 002-3060-11 $422.45 ACTAVIS ADDS AMPHETAMINE SALT MIX ER

More information

Step Therapy Approval Criteria

Step Therapy Approval Criteria Effective Date: 01/01/2019 This document contains for the following medications: 1. Colcrys (colchicine) 2. Dovonex (calcipotriene) 3. Enbrel (etanercept) 4. Humira (adalimumab) 5. Imitrex Injection vial

More information

BlueLink TPA FlexRx Updates

BlueLink TPA FlexRx Updates BlueLink TPA FlexRx Updates April 2018 TRADE NAME (generic name) or generic name abacavir sulfate soln 20 mg/ml (base equiv) Generic Addition, generic for ZIAGEN alclometasone dipropionate cream 0.05%

More information

Antiretrovial Crushable/Liquid Formulation Chart

Antiretrovial Crushable/Liquid Formulation Chart Antiretrovial Crushable/Liquid Formulation Chart Eliza Dollard, PharmD; Nafeesa Chin-Beckford, PharmD; Laura Aragon, PharmD Last Updated: 04/2016 Agent How Supplied Crushable Status **Products listed in

More information

Case 1:14-cv LPS Document 195 Filed 01/05/16 Page 1 of 5 PageID #: 6023

Case 1:14-cv LPS Document 195 Filed 01/05/16 Page 1 of 5 PageID #: 6023 Case 1:14-cv-00121-LPS Document 195 Filed 01/05/16 Page 1 of 5 PageID #: 6023 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE FOREST LABO RA TORIES, INC., FOREST LABO RA TORIES HOLDINGS,

More information

A study on Metformin (1, 1-Dimethylbiguanidemonohydrochloride) reported adverse events as observed in Eudravigilance database

A study on Metformin (1, 1-Dimethylbiguanidemonohydrochloride) reported adverse events as observed in Eudravigilance database A study on Metformin (1, 1-Dimethylbiguanidemonohydrochloride) reported adverse events as observed in Eudravigilance database Contract Research Organization / Terzetto Pharma Metrics NIVETHA CHELLAPATHY

More information

Step Therapy Medications

Step Therapy Medications Step Therapy Medications Step Therapy (ST PA ) is an automated form of prior authorization. It encourages the use of therapies that should be tried first, before other treatments are covered, based on

More information

Alprazolam 0.25mg, 0.5mg, 1mg tablets

Alprazolam 0.25mg, 0.5mg, 1mg tablets Presbyterian Senior Care (HMO) / Presbyterian MediCare PPO Quantity Limits Effective November 1, 2014 For the most recent list of drugs or other questions, please contact the Presbyterian Customer Service

More information

Quantity Limits 2016 Paramount Medicare Formulary Formulary ID: Version 26 Updated: 11/1/2016

Quantity Limits 2016 Paramount Medicare Formulary Formulary ID: Version 26 Updated: 11/1/2016 Quantity Limits 2016 Paramount Medicare Formulary Formulary ID: 16162 Version 26 Updated: 11/1/2016 ANALGESICS acetaminophen w/ codeine (300-15 mg, 300-30 mg, 300-60 mg) acetaminophen w/ codeine soln 120-12

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: Step Therapy Reference Number: HIM.PA.109 Effective Date: 08.01.17 Last Review Date: 05.18 Line of Business: Health Insurance Marketplace Revision Log See Important Reminder at the end

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) A05/11.5/08 A38/20.1.1/0406

More information

2017 Formulary Changes Year to Date

2017 Formulary Changes Year to Date 2017 Formulary Changes Year to Date Health Choice Arizona may add or remove drugs from our formulary during the year. If we remove drugs from our formulary, add prior authorization, quantity limits and/or

More information

PORTFOLIO MADE WITH CARE. FDF Generics Chlorhexidine API

PORTFOLIO MADE WITH CARE. FDF Generics Chlorhexidine API PORTFOLIO MADE WITH CARE FDF Generics Chlorhexidine API MADE WITH CARE Generics API LONG-TERM WORLDWIDE EXPERIENCE FDF HPAPI Intermediates API SEAMLESS DEVELOPMENT FDF FIRST TO MARKET GENERICS FDF MOLECULE

More information

TABLE OF CONTENTS 1 Table of Contents 2 Introduction 3 Key Marketed Products

TABLE OF CONTENTS 1 Table of Contents 2 Introduction 3 Key Marketed Products TABLE OF CONTENTS 1 Table of Contents 1.1 List of Tables 1.2 List of Figures 2 Introduction 2.1 Epidemiology 2.2 Symptoms 2.3 Etiology 2.4 Pathophysiology 2.5 Co-morbidities and Complications 2.6 Classification

More information

ALLERGIC CONJUNCTIVITIS AGENTS

ALLERGIC CONJUNCTIVITIS AGENTS 2018 5 Tier Standard- Keystone First VIP Choice Document: 2018 Step Therapy Formulary ID: 18390 Last Updated: 04/2018 Effective Date: 05-01-2018 ALLERGIC CONJUNCTIVITIS AGENTS epinastine 0.05 % eye drops

More information

SOLID DOSAGE FORMULATIONS

SOLID DOSAGE FORMULATIONS SOLID DOSAGE FORMULATIONS Jubilant Generics, is one of the business arms of J Jubilant Pharma Group, catering to Dosage Formulations (DF) & Active Pharmaceutical Ingredients (API) business segment across

More information

Step Therapy Medications

Step Therapy Medications Step Therapy Medications Step Therapy Group APTIOM Step-2: APTIOM 200 MG TABLET or APTIOM 400 MG TABLET or APTIOM 600 MG TABLET or APTIOM 800 MG TABLET Step 1 Drug(s): Oxcarbazepine immediate-release,

More information

ACYCLOVIR OINT (CCHP2017)

ACYCLOVIR OINT (CCHP2017) ACYCLOVIR OINT (CCHP2017) acyclovir 5 % topical ointment Step Therapy requires trial of one (1) of the following: oral generic acyclovir, oral generic famciclovir, oral generic valacyclovir. 1 ALPHAGAN

More information

ALOGLIPTIN STEP. Step Therapy Requirements Effective April 1, 2018

ALOGLIPTIN STEP. Step Therapy Requirements Effective April 1, 2018 Step Therapy Requirements Effective April 1, 2018 ALOGLIPTIN STEP alogliptin 12.5 mg tablet alogliptin 12.5 mg-metformin 1,000 mg tablet alogliptin 12.5 mg-metformin 500 mg tablet alogliptin 12.5 mg-pioglitazone

More information

ACYCLOVIR OINT (CCHP2017)

ACYCLOVIR OINT (CCHP2017) ACYCLOVIR OINT (CCHP2017) acyclovir 5 % topical ointment Step Therapy requires trial of one (1) of the following: oral generic acyclovir, oral generic famciclovir, oral generic valacyclovir. 1 ALPHAGAN

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 08/5.1/09 INGELHEIM 08/5.1/10

More information

LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON S FOR ISSUE ON 14.03.2016 IMPORT S.NO. NAME OF APPLICANT DIARY NO. TYPE OF 1. TABLETS (INDIA) LIMITED 5973 APPROVAL 2. TABLETS (INDIA) LIMITED 5974 APPROVAL 3. CLARIS OTSUKA PRIVATE LIMITED 7373 APPROVAL

More information

MEDICINES CONTROL COUNCIL

MEDICINES CONTROL COUNCIL MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 41/20.1.1/0039 SCP MYLAN

More information

ALOGLIPTIN STEP. Step Therapy Requirements Effective June 1, 2018

ALOGLIPTIN STEP. Step Therapy Requirements Effective June 1, 2018 Step Therapy Requirements Effective June 1, 2018 ALOGLIPTIN STEP alogliptin 12.5 mg tablet alogliptin 12.5 mg-metformin 1,000 mg tablet alogliptin 12.5 mg-metformin 500 mg tablet alogliptin 12.5 mg-pioglitazone

More information

Blue Cross and Blue Shield of Minnesota GenRx Formulary Updates

Blue Cross and Blue Shield of Minnesota GenRx Formulary Updates Blue Cross and Blue Shield of Minnesota GenRx Formulary Updates July 2018 TRADE NAME (generic name) or generic name ADVAIR DISKUS (fluticasone-salmeterol aer powder ba 100-50 mcg/dose) Brand Addition ADVAIR

More information

2018 Formulary Update

2018 Formulary Update MEDICARE ADVANTAGE BlueShield of Northeastern New York 2018 Formulary Update BlueShield of Northeastern New York has updated its formulary (drug list) since its original publication in January 2018. This

More information

Health Partners Medicare Special 2018 Formulary Changes

Health Partners Medicare Special 2018 Formulary Changes Health Partners Medicare Special 2018 Changes Changes occur, for example, because new drugs come on the market, a drug is moved to a different cost-sharing level (tier), or a generic version becomes available.

More information

2013 Preferred Drug List An evidence-based pharmacy program that works for you

2013 Preferred Drug List An evidence-based pharmacy program that works for you 2013 Preferred Drug List An evidence-based pharmacy program that works for you What is the Moda Health Preferred Drug Program? The Moda Health Preferred Drug Program is a pharmacy program that is designed

More information

2016 Drug Trend Report COMMERCIAL

2016 Drug Trend Report COMMERCIAL 2016 Drug Trend Report COMMERCIAL THERAPY CLASS REVIEW MARKET FACTORS METHODOLOGY Table of contents Introduction 3 Therapy class review 6 Bending the curve on drug spending in 2016 7 Top 15 therapy classes

More information

PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Select Formulary April 1, 2018 Updates. Formulary Alternatives

PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Select Formulary April 1, 2018 Updates. Formulary Alternatives PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Select April 1, 2018 Updates Drug Name adapalene-benzoyl-peroxide Gel 0.1-2.5% (Brand = Epiduo ) prasugrel hcl (Brand = Effient ) vigabatrin pak 500 mg (Brand

More information

Table A1: Fifty Most Often Repeated Oral Drug Product Shortages (35 ingredients), Canada,

Table A1: Fifty Most Often Repeated Oral Drug Product Shortages (35 ingredients), Canada, 1 Appendix Commentary 515 Appendix: Assessing Canada s Drug Shortage Problem Table A1: Fifty Most Often Repeated Oral Drug Product Shortages (35 ingredients), Canada, 2013 16 Drug Name Dosage Therapeutic

More information

ACYCLOVIR OINT (CCHP2017)

ACYCLOVIR OINT (CCHP2017) ACYCLOVIR OINT (CCHP2017) acyclovir 5 % topical ointment Step Therapy requires trial of one (1) of the following: oral generic acyclovir, oral generic famciclovir, oral generic valacyclovir. 1 ALPHAGAN

More information

2018 Formulary Update

2018 Formulary Update MEDICARE ADVANTAGE BlueShield of Northeastern New York 2018 Formulary Update BlueShield of Northeastern New York has updated its formulary (drug list) since its original publication in January 2018. This

More information

formulations Product List- row

formulations Product List- row Solid Dosage formulations Product List- row Therapy Products Strengths Innovator Brand Benazepril + HCTZ 5+ 6.25mg, 10+12.5mg, 20+12.5mg, 20+25mg Brand Name Lotensin HCT Company Validus Pharma Candesartan

More information

HIV Drug Market by Medication class (multi-class combination drugs, nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse

HIV Drug Market by Medication class (multi-class combination drugs, nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse HIV Drug Market by Medication class (multi-class combination drugs, nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), protease inhibitors (PIs),

More information